4,000th article published in Frontiers in Pharmacology
Frontiers in Pharmacology publishes 4000th article [...]
Frontiers in Pharmacology
Collaboration with INPST to explore science behind natural products and promote science communication
A new collaboration with the International Natural Product Sciences Taskforce (INPST) explores the science behind natural products and promotes science communication [...]
Prof Giuseppe Remuzzi heads new Renal Pharmacology specialty section
The latest Frontiers in Pharmacology section promotes cutting-edge discoveries contributing to the goal of eliminating renal dialyses and deaths from kidney diseases. [...]
Pharmacology milestone: 3,000th article published today!
The article, on the role of adenosine receptors in Amyotrophic Lateral Sclerosis (or motor neuron disease), comes from scientists at the University of Lisbon, Portugal. [...]
Long-term caffeine worsens symptoms associated with Alzheimer’s disease
Low caffeine doses worsened neophobia, anxiety-related behaviors and emotional and cognitive flexibility: Frontiers in Pharmacology [...]
Frontiers in Pharmacology welcomes new Field Chief Editor
Professor Heike Wulff appointed as new Field Chief Editor for the journal. [...]
Frontiers journal ranking analysis: Pharmacology & Pharmacy
Frontiers in Pharmacology continues to rank among the world’s top pharmacology journals in terms of influence and quality. [...]
Plant reveals anti-Alzheimer’s compounds
Japanese scientists develop a new technique to isolate active therapeutic compounds for Alzheimer's disease from plants. [...]
Preventing long-term effects after drug holidays in cancer patients
Computer modelling suggests that drug combinations could protect from long-term drug level reductions in certain patients after a break from anti-cancer drug. [...]
Treating babies in the womb for deadly diseases
New understanding of the immune system and stem cell technology gets scientists closer to treating deadly fetal diseases even before birth [...]
Should we treat aging as a disease?
Academic, pharmaceutical, healthcare policy and pension fund perspectives. — By Elliott Williams “The fundamental questions of whether aging can and should be [...]
Quality and Impact Analysis: Frontiers in Pharmacology
Frontiers in Pharmacology has an Impact Factor of 4.418 and is the #2 most cited open-access journal in Pharmacology. [...]
Quality and Impact Analysis: Frontiers in Pharmacology
Frontiers in Pharmacology was launched in 2010. In just 4 years, it has become the 3rd largest and the 2nd most cited open access journal in Pharmacology & Pharmacy. [...]
